Related Experiment Video

Updated: Nov 4, 2025

A Faster, High Resolution, mtPA-GFP-based Mitochondrial Fusion Assay Acquiring Kinetic Data of Multiple Cells in Parallel Using Confocal Microscopy
10:45

A Faster, High Resolution, mtPA-GFP-based Mitochondrial Fusion Assay Acquiring Kinetic Data of Multiple Cells in Parallel Using Confocal Microscopy

Published on: July 20, 2012

16.8K

Mitochondrial Fusion Protein Mfn2 and Its Role in Heart Failure

Lei Chen1, Bilin Liu1, Yuan Qin1,2

  • 1Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.

Frontiers in Molecular Biosciences
|May 24, 2021
PubMed

Insights

Mitofusin 2 (Mfn2) regulates mitochondrial networks and is vital for heart health. Mfn2 dysfunction is linked to heart failure, highlighting its critical role in cardiovascular disease.

Area of Science:

  • Mitochondrial biology
  • Cardiovascular research
  • Molecular medicine

Background:

  • Mitofusin 2 (Mfn2) is a key protein in mitochondrial outer membrane dynamics.
  • Mfn2 regulates mitochondrial fusion, reticulum-mitochondria contacts, quality control, and apoptosis.
  • Mfn2 dysfunction is implicated in cardiovascular pathologies like heart failure.

Purpose of the Study:

  • To review the structure and function of Mitofusin 2 (Mfn2).
  • To elucidate the critical role of Mfn2 in the context of heart failure.

Main Methods:

  • Literature review of Mfn2 structure and function.
  • Analysis of Mfn2's involvement in cardiovascular diseases, particularly heart failure.

Main Results:

  • Mfn2's multifaceted roles in mitochondrial network maintenance are detailed.
  • Evidence linking Mfn2 dysregulation to the pathogenesis of heart failure is presented.

Conclusions:

  • Mfn2 is essential for maintaining mitochondrial integrity and function.
  • Understanding Mfn2's role offers potential therapeutic targets for heart failure.
Keywords:
Mfn2endoplasmic reticulum–mitochondria contactsheart failuremitochondria fusionmitophagy

More Related Videos

Immunodetection of Outer Membrane Proteins by Flow Cytometry of Isolated Mitochondria11:53

Immunodetection of Outer Membrane Proteins by Flow Cytometry of Isolated Mitochondria

Published on: September 18, 2014

15.7K
Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer11:26

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

8.9K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
139
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
183
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.3K